• Healthcare Costs of Inflammatory Bowel Disease in The Biologic Era- A Study Of 2,451 Patients with Twelve years Follow-Up Evaluation

    Nov 1, 2016, 00:00

  • Real-World Evidence of Ruxolitinib In The Treatment of Myelofibrosis- Experince of A Portuguese Hospital Center

    Nov 1, 2016, 00:00

  • Analysis of Hta Requirements Across 10 Emerging and Developed Countries

    Nov 1, 2016, 00:00

  • The Impact of Country-Specific Utility Tariffs on the Outcome of Cost-Utility Analyses; A Case Study

    Nov 1, 2016, 00:00

  • Longitudinal Trajectories of Depressive and Anxious Symptoms Following a Self-Management Intervention for Haemodialysis Patients

    Nov 1, 2016, 00:00

  • Skeletal-Related Events (SRES) and Renal Function in Patients with Symptomatic Multiple Myeloma (MM)- Results from Belgium, France, Germany, Italy, Spain, Switzerland and The United Kingdom

    Nov 1, 2016, 00:00

  • The Societal Impact Of Natalizumab Treatment In The Italian Relapsing-Remitting Multiple Sclerosis Clinical Practi The Tysabri® Pharmacoeconomics (Type) Study

    Nov 1, 2016, 00:00

  • Assessment Of Regional Legislation Related To The Use Of Similar Biological Medicinal Products- The Italian Case Study

    Nov 1, 2016, 00:00

  • Use of Sutureless Prosthesis Neutralizes Expected Worse Economic Impact of High Risk Patients Undergoing Aortic Valve Replacement

    Nov 1, 2016, 00:00

  • A Retrospective, Cross Sectional Study on The Prevalence of Hyperuricemia Using A Healthcare Database In Japan

    Nov 1, 2016, 00:00

  • Bio-Similar Or Different? – Understanding The Payer Perspective

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Roflumilast As Add-On To Triple Inhaled Therapy Vs Triple Inhaled Therapy In Patients with Severe And Very Severe COPD Associated with Chronic Bronchitis In Sweden

    Nov 1, 2016, 00:00

  • A Systematic Literature Review of Cysteamine Bitartrate Preparations in Patients with Cystinosis

    Nov 1, 2016, 00:00

  • Use of the Pert and Uniform Distributions with the Central Limit Theorem (CLT) to Decrease Variance in Complication Cost Estimation in Probabilistic Models

    Nov 1, 2016, 00:00

  • The Economic Impact of Influenza-Like Illness on Families Living in the UK Demonstrated by the Collection of Online Data

    Nov 1, 2016, 00:00

  • The Clinical and Economic Impact of School-Based Quadrivalent Human Papillomavirus Vaccine on Female or Both Genders in Singapore

    Nov 1, 2016, 00:00

  • The Role of Weight Loss or Gain In Payer Assessment of Diabetes Drugs

    Nov 1, 2016, 00:00

  • The 21-Gene Assay In The Decision Impact Assessment of ER+, HER2- Breast Cancer- A French Real Life Prospective Study

    Nov 1, 2016, 00:00

  • Literature Review on Hospital Costs for Patients Undergoing Gastrectomy

    Nov 1, 2016, 00:00

  • Investigation About Influence Of Management Strategy In National Hospital Organization (Nho) Hospitals By The Revision Of Medical Fee Schedule

    Nov 1, 2016, 00:00

  • Health Care Costs Among COPD Patients Are Doubled Compared to A Control Population

    Nov 1, 2016, 00:00

  • Impact of Community Care Subsidies on Care Use Of Elderly People

    Nov 1, 2016, 00:00

  • The Outcomes of A Pharmaceutical Care Assistance Program in A Romanian Community Pharmacy

    Nov 1, 2016, 00:00

  • Health Technology Assessment In Brazil- Metrics From The Reports Of The National Commission For Incorporation Of Technologies (Conitec)

    Nov 1, 2016, 00:00

  • Comparison of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) and the American Society of Clinical Oncology (Asco) Framework for Assessing Value in Cancer Care

    Nov 1, 2016, 00:00

  • The Economic Impact of Schizophrenia from an English NHS Perspective Based on Estimates from Electronic and Self-Reported Methods of Data Collection

    Nov 1, 2016, 00:00

  • Irrational Use of Antibiotics in Turkey

    Nov 1, 2016, 00:00

  • Systematic Review of Cost-Effectiveness Models in Diabetes for Insulin Analogues

    Nov 1, 2016, 00:00

  • Treatment Gap of Post Osteoporotic Fractures in Taiwan- A Nationwide Cohort Study, 2008-2013

    Nov 1, 2016, 00:00

  • Time to Diabetes Related Complications for Newly Diagnosed Diabetes Patients in Singapore

    Nov 1, 2016, 00:00

  • The Role of Budget Impact on HTA Rejection of Oncology Drugs in Romania

    Nov 1, 2016, 00:00

  • Value of Expanding Hcv Treatment Capacity in Germany Through Novel, Effective and Shorter Duration Therapies

    Nov 1, 2016, 00:00

  • Comparison of Orphan Drug Market Access in A Sample of EU Countries, Ausralia, Canada and US

    Nov 1, 2016, 00:00

  • Effects of The Mental Health Parity and Addictions Equality Act on Depression Treatment Choice in Primary Care Facilities in The United States

    Nov 1, 2016, 00:00

  • Economic Value of Eptfe Stent-Grafts Compared to Balloon Angioplasty for Treating Thrombosed and Dysfunctional Arteriovenous Grafts in England

    Nov 1, 2016, 00:00

  • The Cost of Cognitive Impairment in Patient with Major Depressive Disorder

    Nov 1, 2016, 00:00

  • Economic Burden of Myelodysplastic Syndromes In Croatia

    Nov 1, 2016, 00:00

  • Patient Preferences Versus Physician Perceptions Of Treatment Decisions In Advance Stage Prostate Cancer

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis on Hepatic Carcinoma Patients with Hepatitis C

    Nov 1, 2016, 00:00

  • Treatment Indications for Antidepressants Prescribed in Primary Care in France, 2006–2015

    Nov 1, 2016, 00:00

  • Effectiveness of Photodynamic Therapy in Patients with Non-Small Cell Lung Cancer- A Population Based Study

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure in Greece

    Nov 1, 2016, 00:00

  • Assessment of Community Pharmacy Services in Malaysia- Perspectives from Community Pharmacists, General Practitioners, Consumers and Health Policy Stakeholders

    Nov 1, 2016, 00:00

  • A Retrospective Premier Database Study to Evaluate Differences Between Progel™ Pleural Air Leak Sealant As Compared with Other Sealants in The Inpatient Surgical Setting

    Nov 1, 2016, 00:00

  • Burden of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS)

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Brand-Name and Generic Warfarin on Stroke and Bleeding Events in Atrial Fibrillation Patients- A 6-Year Population-Based Retrospective Cohort Study in Taiwan

    Nov 1, 2016, 00:00

  • Clinical Evaluation of Amritha Guggulu in the Management of Gout

    Nov 1, 2016, 00:00

  • Markov Models For Health Economic Evaluation Modelling In R With The Heemod Package

    Nov 1, 2016, 00:00

  • Current Perioperative Use of Orodental Antiseptics In Implant Surgery In Bulgaria

    Nov 1, 2016, 00:00

  • Economic Evaluation of Drug Wastage Impact on Healthcare Expenditures in French Hospitals

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of The Introduction Of Biosimilars In A Belgian Tertiary Care Hospital- A Simulation

    Nov 1, 2016, 00:00

  • Treatment Patterns And Drug-Related Costs For Patients with Psoriasis on Biologic Therapy- A Retrospective Cohort Study In Southern Italy

    Nov 1, 2016, 00:00

  • Medication Errors Avoided by Medication Reconciliation Process at Female Surgery Ward in Ramathibodi Hospital, Thailand

    Nov 1, 2016, 00:00

  • Assessing The Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Inoperable Patients with Severe Aortic Stenosis in UK

    Nov 1, 2016, 00:00

  • The Economic Value of Rapid Deployment Aortic Valve Replacement Via Full Sternotomy

    Nov 1, 2016, 00:00

  • Assessment of Carotid Stenting Safety- A French Exhaustive Cohort Study Based on The Re-Use of Routine National Health Database

    Nov 1, 2016, 00:00

  • Impact of Etanercept Biosimilar Launches on Healthcare Spending- A UK Budget Impact Model For The Treatment of Rheumatoid Arthritis And Chronic Plaque Psoriasis

    Nov 1, 2016, 00:00

  • Cost of Illness of Ankylosing Spondylitis In Egypt From Payer Prospective

    Nov 1, 2016, 00:00

  • Changes of The Reimbursement Recommendations Focused on Oncology Drugs Before and after The Implementation of The 2013 Benefit Enhancement Policy in Korea

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Biphasic Insulin Aspart 50 Versus Biphasic Human Insulin 50 in People with Type 2 Diabetes Mellitus in China

    Nov 1, 2016, 00:00

  • What is Real-World Data?- A Review of Definitions Based on Literature Stakeholder Interviews

    Nov 1, 2016, 00:00

  • Economic Burden of Ankylosing Spondylitis In Europe. A Systematic Review of The Literature

    Nov 1, 2016, 00:00

  • Cost Comparison in the Management of the Renal Cell Carcinoma with in Spain- Pazopanib vs. Sunitinib

    Nov 1, 2016, 00:00

  • Universal Mass Vaccination With Phid-Cv Is Cost-Effective In Croatia

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Evaluating Vortioxetine Versus Venlafaxine XR and Agomelatine in the Treatment of Major Depressive Disorder in Taiwan

    Nov 1, 2016, 00:00

  • A Restrospective Non-Interventional Study Among Patients with Relapsing Multiple Sclerosis Switching to Fingolimod or to Other Disease Modifying Therapies

    Nov 1, 2016, 00:00

  • “Best Supportive Care” or “Therapy According to Physician's Choice” as Appropriate Comparator for German HTA Dossiers – An Underestimated Chance or Risk for the Benefit Assessment?

    Nov 1, 2016, 00:00

  • The Indirect Costs of Breast Cancer in The Slovak Republic

    Nov 1, 2016, 00:00

  • Epidemiology, Treatment Pathways and Costs of Cancers Potentially Related to HPV Infection in France

    Nov 1, 2016, 00:00

  • Status and Expenses- Re-Use Of Insulin Syringe Needles in the Diabetic Patients in Beijing

    Nov 1, 2016, 00:00

  • Impact of Whole Exome Sequencing (WES) on Costs and Medical Decision-Making

    Nov 1, 2016, 00:00

  • Modeling Treatments and Outcomes in Metastatic Castration-Resistant Prostate Cancer- A Case Study of Discrete Event Simulation and the Challenges for A UK Nice Evaluation

    Nov 1, 2016, 00:00

  • Using Analytic Hierarchy Process to Weight Patient-Relevant Outcomes in the Treatment of Psoriasis for Calculating the Patient Benefit Index

    Nov 1, 2016, 00:00

  • Early Payer Scientific Advice Procedures In The Eu- Which One Is Most Suited For Pharmaceutical Compaines?

    Nov 1, 2016, 00:00

  • Policies for Use of Real-World Data in Health Technology Assessment- A Comparative Study of 6 HTA Agencies

    Nov 1, 2016, 00:00

  • Managed Entry Agreements- Portuguese Experience

    Nov 1, 2016, 00:00

  • A Study Comparing the Evolution of Different Proceeses for Patient Input in Different European HTA Systems Since 2011

    Nov 1, 2016, 00:00

  • Stock Reduction of Erythropoietin for Patients on Hemodialysis at Somdech Phra Debaratana Medical Center

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis Of Tedizolid For The Treatment Of Acute Bacterial Skin And Skin Sub-Structure Infections (Absssi) In Greece

    Nov 1, 2016, 00:00

  • Exploring The Socioeconomic Impact Of Post Approval Change Requirements For Vaccines

    Nov 1, 2016, 00:00

  • Costs And Quality of Life of Low Back Pain- A Multi-Register Based National Treatment Pathway Model In Sweden

    Nov 1, 2016, 00:00

  • Prevalence and Patient Characteristics of Multiple Sclerosis (Ms) in Japan

    Nov 1, 2016, 00:00

  • Treatment Pattern of Antibiotics and Cost Analysis in Sepsis Patients- A Cross Sectional Retrospective Prospective Study

    Nov 1, 2016, 00:00

  • Mapping of Existing Data Sources for the Conduct of Real-World Studies on Lung Cancer in China

    Nov 1, 2016, 00:00

  • Cost Minimisation Analysis Of Follitropin Delta Versus Follitropin Alfa In Assisted Reproductive Technologies (Ivf/Icsi) In The United Kingdom

    Nov 1, 2016, 00:00

  • The assessment of advanced medicinal products (atmp) in germany- is the practice to define atmp drugs as procedures in compliance with european legislation?

    Nov 1, 2016, 00:00

  • The Prevalence of Atypical Antipsychotic Medication Use For Pediatric Psychosis in Korea

    Nov 1, 2016, 00:00

  • Indirect Treatment Comparison of Ustekinumab Versus Other Biologics In Moderate To Severe Crohn’s Disease- A 1-Year Treatment Sequence Analysis

    Nov 1, 2016, 00:00

  • Detection and Analysis of Therapy Lines and Other Event Sequences in Claims Data

    Nov 1, 2016, 00:00

  • Incremental Burden of Cancer in Patients Undergoing Hepatic Resections- Results From A National Hospital Billing Data

    Nov 1, 2016, 00:00

  • Modelling The Economic Impact of Implementing Treatment-Free Remission (TFR) In Philadelphia+ (PH+) Chronic Myelogenous Leukemia In Chronic Phase (CML-CP) Patients Treated In First Line (1l) With The Tyrosine Kinase Inhibitors (TKI)- Imatin ...

    Nov 1, 2016, 00:00

  • Assessment of Criteria Influences on Judicious Selection of New Drug for Future Coverage Policy in Iran- An Analysis with Structural Equation Modeling

    Nov 1, 2016, 00:00

  • Health Technology Assessment in Argentina- At what Point in the Life-Cycle of Technologies are they Requested

    Nov 1, 2016, 00:00

  • An Economic Analysis on Optimal Management of Fragility Hip Fractures In Geriatric Patients Adopting The Geriatric Fracture Program

    Nov 1, 2016, 00:00

  • The Adoption Trends of Robotic-Assisted Benign Hysterectomy in United States From 2008 to 2014

    Nov 1, 2016, 00:00

  • Towards Improved Cervical Cancer Primary Screening in Austria - A Decision-Analytic Benefit-Harm Analysis

    Nov 1, 2016, 00:00

  • Willingness to Pay For A Quality-Adjusted Life Year of Outpatients with Cardiovascular Diseases

    Nov 1, 2016, 00:00

  • Development Of Predictive Models For The Analysis Of The List Of Vital Essential And Necessary Drugs Compilation

    Nov 1, 2016, 00:00

  • France-Spain Comparison of Hospital Delivery Mode Between 2006 And 2014 According Comorbidity Profiles of Patients

    Nov 1, 2016, 00:00

  • Utilisation and Dosage Patterns of Intravenous Echinocandins for Treatment of Invasive Fungal Infections Within Hospitals in England

    Nov 1, 2016, 00:00

  • Getting Medical Innovation to Patients in Developing Countries - A Systemic Approach to Setting Price and Access

    Nov 1, 2016, 00:00

  • The Introduction of Etanercept Biosimilar In The Practice of A Tertiary Rheumatologic Centre In Italy- A Budget Impact Model

    Nov 1, 2016, 00:00

  • Avoidable Hospitalizations Through Effective Primary Care At A Pediatric Hospital In The Colombian Caribbean

    Nov 1, 2016, 00:00

  • Real-World Health Outcomes, Economic Impacts, and Cost-Effectiveeness of a Beijing Municipal Government Funded Free-Drug Rpogram in Community Schizophrenia Patients in Beijing, China

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Acupuncture Treatment In Mental Disorder- A Systematic Review

    Nov 1, 2016, 00:00

  • Generic Drug Utilization Among The Elderly With Multiple Chronic Conditions In The United States

    Nov 1, 2016, 00:00

  • Open Versus Endovascular Repair in Patients with Abdominal Aortic Aneurysm in Spain ─ A Cost Comparisson

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes in Spondyloarthritis Patients in Europe- A Systematic Review of the Literature

    Nov 1, 2016, 00:00

  • Adherence to Osteoporosis Drugs and Clinical Outcomes Among Osteoporosis Patients with Different Risk Profiles

    Nov 1, 2016, 00:00

  • Assessment of CTX-1 Bone Biomarker As An Indicator of Antiresorptive Therapy Efficacy And of Persistence In A Fracture Liaison Service

    Nov 1, 2016, 00:00

  • Evaluation Of The Impact Of Pharmacists Qualification And Years Of Practice On Pharmaceutical Care Services In Community Pharmacy Practice In Enugu Nigeria

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Lanreotide Autogel 120 Mg in the Treatment of Acromegaly in Poland

    Nov 1, 2016, 00:00

  • Nintedanib Cost-Effectiveness In Idiopathic Pulmonary Fibrosis In The UK

    Nov 1, 2016, 00:00

  • Treatment Resistant Depression Development From Major Depressive Disorder- A Claims Database Analysis In Japan

    Nov 1, 2016, 00:00

  • Impact of Medication Therapy Management Service Provided by Clinical Pharmacists on Drug Therapy of Patients Undergoing Hemodialysis

    Nov 1, 2016, 00:00

  • Prevalence of Therapy-Resistant Hypercholesterolemia in High-Risk Cardiovascular Patients in Germany

    Nov 1, 2016, 00:00

  • Well-Being- What Is It, How Does it Compare to Health and What are the Implications of Using it to Inform Health Policy?

    Nov 1, 2016, 00:00

  • The Impact of Treatment Adherence on Clinical and Economic Outcomes in Multiple Sclerosis- Real-World Evidence from Alberta, Canada

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis To Estimate The Cost Savings from Alectinib on Patients With Anaplastic Lymphoma Kinase (ALK) Positive Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) Previously Treated with Crizotinib

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Omalizumab for the Treatment of Chronic Spontaneous Urticaria in France

    Nov 1, 2016, 00:00

  • The Effectiveness of Lean Body Mass Analysis Using Dual Energy X-Ray Absorptiometry (DEXA) for Diagnosis of Sarcopenia

    Nov 1, 2016, 00:00

  • A UK Observational Cohort Study of Insulin Treatment Patterns and Characterisation of Insulin Users in Type 1 And Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • A Health Outcomes Model Showing Stroke Prevention in Atrial Fibrillation and Cost-Savings in England

    Nov 1, 2016, 00:00

  • Costs of Care Between Resected and Non-Resected Pancreatic Cancer Patients- Findings from a Real-World U.S. Population

    Nov 1, 2016, 00:00

  • Analysis Of Influenza Vaccination Effectiveness In General Practitioner

    Nov 1, 2016, 00:00

  • Consumer Perception of Communication with Healthcare Professionals (HCPS) and Information Clarity Concerning Newly Prescribed Medication

    Nov 1, 2016, 00:00

  • The Influence Of Price Regulation Method On Price Trajectory – Assessment Of Cancer Drug Prices In Usa, The Uk And Israel

    Nov 1, 2016, 00:00

  • Cancer Immunotherapy with Checkpoint Inhibitors is Associated with Immune-Mediated Reactions- A Pharmacovigilance Study

    Nov 1, 2016, 00:00

  • The Impact Of Cost Sharing Arrangements In The Use Of Health Care Services During The Economic Crisis In Greece And The Attitudes Of Citizens

    Nov 1, 2016, 00:00

  • What are the Most Important Decision-Making Criteria For Innovative Health Technology Integration? A National Survey from French Hospitals Decision-Makers

    Nov 1, 2016, 00:00

  • Application of Value of Information Analysis To Minimize Decision Risk In Malaysia

    Nov 1, 2016, 00:00

  • Guidance On Selecting Appropriate Methods When Considering Adjusting Overall Survival For Treatment Switch In Oncology Studies

    Nov 1, 2016, 00:00

  • Quality of Life of Patients with Alzheimer's Disease - A Comparison with General Population

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Interventions on Non-Alcoholic Fatty Liver Disease (NAFLD)- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Evaluating the Effectiveness of Treatments of Opioid use Disorder Based on Recovery Outcomes- How to Bridge the Disconnect Between Clinical Trial Outcomes and Recovery Outcomes?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of A Preventive Testing Strategy in Relatives of Patients with BRCA Mutated Ovarian Cancer Versus A No Test Strategy

    Nov 1, 2016, 00:00

  • Translation of the DN4 (Douleur Neuropathique EN 4 Questions) INTO 85 Languages- Challenges and Importance of the Conceptual Defintion of the Original Version

    Nov 1, 2016, 00:00

  • Therapeutic Indication of Lyophilized Hydrocortisone to the Treatment of Trichinosis with Neurological and / or Myocardial Involvement

    Nov 1, 2016, 00:00

  • The GM Ahsn Af Landscape Tool- A Shared Data Platform to Identify Health and Economic Opportunities to Reduce Incidence of Stroke Through Effective Anticoagulant Management of Patients with Atrial Fibrillation in Greater Manchester

    Nov 1, 2016, 00:00

  • Evaluation of Methodological Variations in the Event Simulation Approaches of Published Health Economic Models in Obesity Prevention and Therapy

    Nov 1, 2016, 00:00

  • Preference For Cervical Cancer Screening In Rural China- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Diareg – Results from an Diabetes Register with Focus on Patient Reported Outcomes

    Nov 1, 2016, 00:00

  • Icpc-2 Episode-Based Health-Related Quality Of Life And Three Months Effectiveness In Three Finnish Primary Health Care Settings

    Nov 1, 2016, 00:00

  • Ict Diffusion and Pharmaceuticals (Issues For Decision Tools)

    Nov 1, 2016, 00:00

  • The Impact of Dementia on the Outcomes of Treatments For Acute Coronary Syndrome

    Nov 1, 2016, 00:00

  • Was the Consistency of Data Improved after Separating the Better than Health (BTD) and Worse than Death (WTD) Tasks and Implementing a Feedback Module (FB) in Composite Time Trade off (CTTO) Exercise?

    Nov 1, 2016, 00:00

  • A Retrospective Study on Association Between Change In Bmi And Incidence Of Hypertension Using A Health Care Database In Japan

    Nov 1, 2016, 00:00

  • Drug Utilization Study of Antibiotics in A Secondary Care Referral Hospital

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sunitinib Versus Best Supportive Care for The Treatment of Metastatic Renal Cell Carcinoma in Chile

    Nov 1, 2016, 00:00

  • Network Meta-Analysis To Assess The Relative Efficacy of Empagliflozin Monotherapy Over 24, 52, And 76 Weeks In Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Mapping of The Biosimilar Drug Policy in 10 Central Eastern European Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal

    Nov 1, 2016, 00:00

  • The Economic Burden of Four Heart Conditions in Brazil

    Nov 1, 2016, 00:00

  • Comparison of Bayesian Network Meta-Analyses in a Winbugs and SAS Framework

    Nov 1, 2016, 00:00

  • Phase III Trial of Recombinant Human Parathyroid Hormone in Hypoparathyroidism- A Post-HOC Analysis of Change in Health-State Utility Among Responders

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Viacoram for The Treatment of Hypertension in Italy

    Nov 1, 2016, 00:00

  • Real-World Outcomes and Resource Utilisation Following Onabotulinumtoxina Treatment For Severe Lower Limb Focal Spasticity in Adults – Database Analysis at An Australian Hypertonicity Clinic

    Nov 1, 2016, 00:00

  • What Is The Hospital Economic Burden Of Hiv In France? Results from an analysis of the national french medical information system database

    Nov 1, 2016, 00:00

  • The Impact of Economic Crisis on Drug Consumption and Pharmaceutical Expenditure in Greece

    Nov 1, 2016, 00:00

  • Clinical Effectiveness Telepsychotherapy for Depression Disorder- A Systematic Review

    Nov 1, 2016, 00:00

  • Is Big Data in Healthcare about Big Hope or Big Hype? Early Health Technology Assessment of Big Data Analytics in Healthcare

    Nov 1, 2016, 00:00

  • The Benefits of Earlier Treatment with Paritaprevir/Rotanavir/Ombitasvir with or without Dasabuvir in Ireland

    Nov 1, 2016, 00:00

  • Adjustment Of OS In Crystal For Post-Study Anti-Cancer Therapies

    Nov 1, 2016, 00:00

  • Meta-Analysis of Newer Anti-Epileptic Drugs for Treatment of Partial Epilepsy in Children

    Nov 1, 2016, 00:00

  • Priority Setting of Medical Device for Patient Safety in Korean Hospitals

    Nov 1, 2016, 00:00

  • Assessing The Cost-Effectiveness of Secukinumab Compared To Tnf Inhibitors As Second Line Biologic Treatment In Psoriatic Arthritis

    Nov 1, 2016, 00:00

  • Sacubitril/Valsartan Estimated Cost Savings Based on Paradigm-HF Results

    Nov 1, 2016, 00:00

  • Pessoa Study – Evaluating The Burden of Psoriasis In Portugal From The Patients’ Perspective (A Patient Reported Outcomes Analysis)

    Nov 1, 2016, 00:00

  • Hospitalization Cost and Length of Stay Associated with HPV-Related Diseases

    Nov 1, 2016, 00:00

  • Determinants of The Impact of The Economic Crisis on General and Oral Health in Greater Athens Area Greece

    Nov 1, 2016, 00:00

  • Validity and Reliability of Three New Instruments for Parents and Children Assessing Nutrition and Physical Activity Behaviors, Environment and Knowledge and Health in Childhood and Adolescence in Greece During the Economic Recession- Data ...

    Nov 1, 2016, 00:00

  • Exercise and Factors Influence Mental Health Of Undergraduated Students At Burapha University In 2014

    Nov 1, 2016, 00:00

  • Cost Utility of Transfer Factor In The Treatment of Recurrent Infection`S Episodes In Adult And Pediatric Subjects From A Final Results From Multicentre Observational Study

    Nov 1, 2016, 00:00

  • A Patient Survey Regarding Risk of Opioid Abuse- Results of A Pilot Study

    Nov 1, 2016, 00:00

  • Payer Requirements in the Treatment of Chronic Heart Failure

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis For The Treatment Of Primary Immunodeficiency Disease (Pidd) In The Mexican Social Security Institute In 2016

    Nov 1, 2016, 00:00

  • Use of Novel Health-Related Quality of Life Measures to Assess The Effect of Metamorphopsia Symptoms In Patients with Vitreomacular Traction, With or Without Macular Hole- The Memo Study

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of A Flash Glucose Monitoring System for Type 2 Diabetes (T2DM) Patients Receiving Intensive Insulin Treatment in Europe

    Nov 1, 2016, 00:00

  • War Rages Between Infliximab Biosimilars and Their Originator

    Nov 1, 2016, 00:00

  • The Therapeutic Indication of Capsule and Injectable Etoposide To The Treatment of Osteosarcoma

    Nov 1, 2016, 00:00

  • Estimating The Economic and Clinical Benefits of Mirabegron Versus Antimuscarinics for The Treatment of Overactive Bladder (OAB) in The United Kingdom (UK)

    Nov 1, 2016, 00:00

  • EFFECTIVENESS OF THE TRX SUSPENSION TRAINER IN PEOPLE WITH OSTEOARTHRITIS

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apremilast In Moderate-To-Severe Psoriasis In Canada

    Nov 1, 2016, 00:00

  • Measuring the Relationship between Hospital Costs and Quality of Care- An Example of Acute Myocardial Infraction in Edmonton, Alberta, Canada

    Nov 1, 2016, 00:00

  • Societal Implications of Medical Insurance Coverage for Imatinib as First-Line Treatment of Chronic Myeloid Leukaemia in China- A Cost Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Lipegfilgrastim in Prophylaxis of Febrile Neutropenia in Cancer Patients

    Nov 1, 2016, 00:00

  • Linguistic Validation of the Injection-Treatment Acceptance Questionnaire (I-TAQ)

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Bevacizumab Compared to Cetuximab and Panitumumab in First-Line Treatment of Kras Wild-Type Metastatic Colorectal Cancer in France

    Nov 1, 2016, 00:00

  • Rate and Healthcare Utilization (Los and Costs) of Adhesion Related Complications after Colon Resection Procedures

    Nov 1, 2016, 00:00

  • Using Orthogonal Design in Selecting Health States for the Construction of EQ-5D-3L Value Set

    Nov 1, 2016, 00:00

  • Cancer Associated Medical Spending- US National Data Between 2000 and 2013

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Using Everolimus or Axitinib in Patients with Metastatic Renal Cell Carcinoma WHO Have Failed to Use of Pazopanib or Sunitinib in First-Line Treatment

    Nov 1, 2016, 00:00

  • Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis- 4-Year Outcomes from the Rapid-Psa Study

    Nov 1, 2016, 00:00

  • Comorbidities in HIV-1- A Literature Review of the Associations Between Patient- and Disease-Related Factors and Non-Aids Related Comorbidities (NARCS)

    Nov 1, 2016, 00:00

  • The Invariance Analysis Of Sf12v2- ¿Are Comparable The Quality Of Life Results Of Men And Women?

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis- A Comparison Between Preset Artery Blood Samplers and Disposable Syringes in Arterial Blood Sampling

    Nov 1, 2016, 00:00

  • When Should Translations of Clinical Outcome Assessments (COAS) be Considered Obsolete? Recommendations from MAPI’S Translations Life Expectancy Working Group

    Nov 1, 2016, 00:00

  • A Network Metanalysis To Compare Biologic Agents In The Treatment of Non-Radiographic Axial Spondyloarthritis

    Nov 1, 2016, 00:00

  • Evaluation of Supportive Care in the Cancer Patients on Chemotherapy in a Developing Country- A Comparision of Clinical Practice with Standard Guidelines

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Tips Procedures with Expanded Polytetrafluoroethylene (EPTFE) Covered Stent-Grafts Compared to Large Volume Paracentesis in Patients with Refractory Ascites – A Spanish Scenario

    Nov 1, 2016, 00:00

  • How are Budget Impact Considerations Captured within Economic Evaluations? A Systematic Review of the Literature Focused on Rotavirus Vaccine

    Nov 1, 2016, 00:00

  • Acceptability of Electronic Patient Reported Outcomes In Clinical Care of HIV

    Nov 1, 2016, 00:00

  • Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spond ...

    Nov 1, 2016, 00:00

  • In-Hospital Mortality and Complications Following Surgical Resection of Glioblastoma

    Nov 1, 2016, 00:00

  • Pain Management of Lung Cancer Patient in Hungary

    Nov 1, 2016, 00:00

  • Healthcare Resource Use Alongside Novel Treatments for Advanced Melanoma in the Netherlands

    Nov 1, 2016, 00:00

  • Management of Patients with Statin Intolerance in Japan, South Korea and Taiwan- Comparison of Results From A Clinician Survey

    Nov 1, 2016, 00:00

  • Work Productivity Activity Impairment Loss of Patients with HER2 Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Retrospective Database Analysis of Hospital Length of Stay, Discharge Location, And Readmissions Among Patients Undergoing Total Knee Arthroplasty (TKA) In The United States

    Nov 1, 2016, 00:00

  • Comparison of Informal Caregiving Time Required by Alzheimer's Disease Patients and Mild Cognitive Impairment Patients

    Nov 1, 2016, 00:00

  • Attributes Defining Patient Engagement And Centeredness In Health Care Research And Practi A Framework Developed By The Ispor Patient-Centered Special Interest Group

    Nov 1, 2016, 00:00

  • New Data on the Burden of Abnormal Pap Smears and Hospitalised Pre-Cancerous Lesions in France (EGB AND PMSI DATABASES ANALYSIS)

    Nov 1, 2016, 00:00

  • Dimensionality Of Value- Are The Us And Europe Moving Towards Similar Or Different Definitions Of Pharmaceutical Value?

    Nov 1, 2016, 00:00

  • Investigating Performance Indicators and Service Quality Improvement in an Outpatient Cardiology Department

    Nov 1, 2016, 00:00

  • Prices And Affordability Of Reimbursed Pharmaceuticals- A European Cross-Country Study

    Nov 1, 2016, 00:00

  • Nothing Ventured, Nothing Gained – Is The Innovation Fund The Catapult to A New Generation of Care Concepts and A Competitive Market in Health Care in Germany?

    Nov 1, 2016, 00:00

  • Workload Analysis Of Parenteral Nutrition Services At Ministry Of Health Hospital In Saudi Arabia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Continuous Intraduodenal Levodopa Intestinal Gel Infusion in the Treatment of Advanced and Severe Forms of Parkinson's Disease

    Nov 1, 2016, 00:00

  • Critical issues influencing cost-effectiveness analyses of pneumococcal vaccine strategy for elderly in japan

    Nov 1, 2016, 00:00

  • The Impact of the Difference in Natural History Models on the Cost-Effectiveness of Antiviral Agents for Patients with Genotype 1 Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • Psychometric Validation Of Four Patient-Reported Outcome Instruments In A Diverse Sample Of Adults With Chronic Hepatitis C Virus Infection Treated With Simeprevir And Sofosbuvir

    Nov 1, 2016, 00:00

  • Free Essential Medicines Through Public Health Facilities in Nepal- A Qualitative Study

    Nov 1, 2016, 00:00

  • Real Life Drug Utilization and Biologics Effectiveness in Patients With Crohn's Disease – A Population-Based Study in Taiwan

    Nov 1, 2016, 00:00

  • Comparison Of The Relationship Between Socio-Economic Status And Health-Related Quality Of Life Amongst Atopic Dermatitis Patients Across Different Healthcare Systems

    Nov 1, 2016, 00:00

  • Comparative Analysis of Indirect Costs Associated with Chronic Spontaneous/Idiopathic Urticaria-Results From The Assure-Csu Study In 7 Countries

    Nov 1, 2016, 00:00

  • Role of Tiered Pricing Policy in Improving Access to Medicines in India

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Ombitasvir/Paritaprevir/Ritonavir With Or Without Dasabuvir For The Treatment Of Chronic Hepatitis C Patients Infected With Genotype 1 Or 4 In France

    Nov 1, 2016, 00:00

  • Adoption of Transcatheter Mitral Valve Repair in Germany- Utilization Patterns and Case Volumes Compared to Mitral Valve Surgery in the Period 2010-2014

    Nov 1, 2016, 00:00

  • A Framework To Guide The Use Of Real-World Evidence To Support Evaluation Of Relative Effectiveness Of New Medicines

    Nov 1, 2016, 00:00

  • Assessing Patient Preference for Insulin Intensification in France

    Nov 1, 2016, 00:00

  • Hyperbolic Discounting of Effects in Economic Evaluations

    Nov 1, 2016, 00:00

  • Health Related Quality of Life Scores in Breast Cancer Survivor Women with and without Breast Reconstruction Surgery

    Nov 1, 2016, 00:00

  • A Real-World Evaluation of the Clinical and Economic Burden of United States Veteran Patients with Post-Traumatic Stress Disorder

    Nov 1, 2016, 00:00

  • The Behaviour Of Pharmacists In Public Pharmacies In Relation To The Cold Regime Drugs

    Nov 1, 2016, 00:00

  • Retrospective Study of Frequency and Cost of Multiple Myeloma (MM) Complications and Treatment Related Adverse Events (AES)

    Nov 1, 2016, 00:00

  • Deep Brain Stimulation Compared to Device-Aided Infusion Therapies for Parkinson’s Disease with Early Motor Complications- A UK Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Role of Clinical Pharmacist in Optimizing Reimbursement Originating from Performance-Based Risk-Sharing Arrangements- The Experience of the University Hospital “G. Martino” from Messina, Italy

    Nov 1, 2016, 00:00

  • Health Related Quality of Life for Disease Population in China- A Systematic Review

    Nov 1, 2016, 00:00

  • Positive Impact of Indacaterol Launch on Guidelines Compliance And Consequences on COPD Daily Treatment Cost In France

    Nov 1, 2016, 00:00

  • Breast Cancer in China- Room for Improved Screening

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Antihypertensive Drugs Usage by Combination of ACEI – CCB and ACEI – Diuretic in Outpatient Hypertension Therapy at Rsal Mintohardjo Jakarta (July-November 2015)

    Nov 1, 2016, 00:00

  • Length of Stay, Costs and Mortality Attributable to Clostridium Difficile Infections in 13 Belgian Hospitals

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Gazyvaro in Association to Chlorambucil for Patients with Chronic Lymphocytic Leukemia When Full-Dose Fludarabine is Unsuitable in France

    Nov 1, 2016, 00:00

  • Is the Orphanage Filling Up? Projecting the Growth and Budget Impact of Orphan Drugs in Europe

    Nov 1, 2016, 00:00

  • G-BA Early Advice VS. EMA/HTA Parallel Advice from a German Perspective

    Nov 1, 2016, 00:00

  • Review Of National Policies For Rare Diseases Across Eu Countries

    Nov 1, 2016, 00:00

  • A Systematic Literature Review to Identify Clinical Drivers in Cost-Effectiveness Analyses in T2DM Patients Uncontrolled on Current Therapies

    Nov 1, 2016, 00:00

  • Pharmaceutical Pricing Strategies In Developing Countries- A Systematic Review

    Nov 1, 2016, 00:00

  • Comparison of the Trends of Orphan Drugs Designations and Approvals in the United States and Europe In Oncology

    Nov 1, 2016, 00:00

  • Feasibility, Reliability and Validity of The Decision Tool Unipolar Depression (DTUD) In Identifying Patients with Major Depressive Disorder in Need of Highly Specialized Care

    Nov 1, 2016, 00:00

  • Systematic Review, Meta-Analysis, and Cost-Effectiveness Model of Invasive Versus Non-Invasive Strategy for Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) in Patients with Prior Coronary Artery Bypass Graft (CABG)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of First-Line S-1 Therapy for Metastatic Breast Cancer Patients Compared with Taxanes- An Analysis Based on the Randomized Phase III Select BC Trial

    Nov 1, 2016, 00:00

  • Compare Policies And Research Situation Of Rare Diseases And Orphan Drugs Between China And Other Countries

    Nov 1, 2016, 00:00

  • A Review of Pharmeceutical Policies in Response to Economic Crisis and Sanctions

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/Valsartan for Heart Failure Patients with Reduced Ejection Fraction in Italy

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns Among Patients with Ovarian Cancer- An Analysis of a Large us Electronic Health Records Database

    Nov 1, 2016, 00:00

  • Health Economic Evaluation of HDM Slit-Tablet For Allergen Immunotherapy In House Dust Mite Induced Allergic Rhinitis with or Without Allergic Asthma In An Italian Setting

    Nov 1, 2016, 00:00

  • Economic Evaluation of Cancer Medicines Usage at Uganda Cancer Institute

    Nov 1, 2016, 00:00

  • A Real Concern Or Just A Hype? – Evidence On Negative Clinical Consequences Of Switching From Originator To Biosimilar Based On A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Nivolumab for the Treatment of Metastatic Melanoma in Chile

    Nov 1, 2016, 00:00

  • Preferences For The Characteristics Of Home Enteral Nutrition (Hen) Via Tube Feeding- A Discrete-Choice Experiment

    Nov 1, 2016, 00:00

  • Evaluation Of The Value Of Pharmaceutical Products In Taiwan

    Nov 1, 2016, 00:00

  • Subatmospheric Pressure Therapy Efficiency for the Treatment of Pressure Ulcers- A Health Techonology Assessment

    Nov 1, 2016, 00:00

  • The Effects of Continues Glucose Monitoring System on Patient Outcomes and Associated Costs

    Nov 1, 2016, 00:00

  • Utilisation of Antithrombotic Drugs in Slovakia

    Nov 1, 2016, 00:00

  • Informal Care and Productivity Losses are Important in Advanced Cutaneous Melanoma- Results of the Dutch Melanoma Treatment Registry

    Nov 1, 2016, 00:00

  • Special Considerations and Patient Access Schemes for Oncology by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries

    Nov 1, 2016, 00:00

  • What Motivates Mothers To Pay For A Vaccine Against Children’s Diarrhea? Preferences for vaccines against children’s diarrheal illness among mothers in poland and hungary

    Nov 1, 2016, 00:00

  • Number Of Patients In Physiotherapy Services Within Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00

  • Economic Burden of Maintaining Vascular Access Patency in Patients with Hemodialysis Fistulas - A National Population-Based Study

    Nov 1, 2016, 00:00

  • Association Between Orphan Drug Prices and Therapeutic Area

    Nov 1, 2016, 00:00

  • Impact of State Mandated Queries of The Prescription Drug Monitoring Programs on Opioid And Non-Opioid Drug Related Adverse Effects- A Difference In Difference Approach

    Nov 1, 2016, 00:00

  • Financial Impact of Intraviteal Ranibizumab or Aflibercepte for Neovascular Age-Related Macular Degeneration and for Macular Edema Secondary to Central Retinal Vein Occlusion Coverage for a Health Care System of Public Employees Located in ...

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab for the Treatment Of Advanced Non-Squamous Non-Small Cell Lung Cancer (Nsclc) In Saudi Arabia

    Nov 1, 2016, 00:00

  • Burden of Disease And Management of Mesothelioma In Fran A National Cohort Analysis

    Nov 1, 2016, 00:00

  • Inpatient Treatment Cost of Stroke- An Analysis in Ho Chi Minh City 115 People's Hospital, Vietnam

    Nov 1, 2016, 00:00

  • Economic Impact of Fentanyl HCL Iontophoretic Transdermal System Versus IV PCA In Acute Pain Management Following Surgery In The United Kingdom, Germany And Sweden

    Nov 1, 2016, 00:00

  • Developing HTA Guidelines for Rare Disease Therapies - an Industry Perspective

    Nov 1, 2016, 00:00

  • Differential Patterns of Persistent Opioid Use in Patients with Cancer and Non-Cancer Pain

    Nov 1, 2016, 00:00

  • To Treat or Watch? Identifying Drivers of Decisions for Patients with GEP-NET Using Reflective Multi-Criteria Decision Analysis

    Nov 1, 2016, 00:00

  • Boosting a Modeller's Armoury- Pursuing Realistic and Efficient Competing Risk Health Economic Models (HEMS)

    Nov 1, 2016, 00:00

  • Predicting Orphan Designation And Marketing Authorisation Based On A Review Of The European Medicines Agency Orphan Disease Register

    Nov 1, 2016, 00:00

  • Economic Evaluation of Tocilizumab Vs Abatacept In Methotrexate-Experienced Patients with Rheumatoid Arthritis In Italy

    Nov 1, 2016, 00:00

  • Review of Economic Evaluation of Saxagliptin in Type2 Diabetes in China

    Nov 1, 2016, 00:00

  • Epidemiological Estimation and Flow of Patients with Advanced Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy in Spain

    Nov 1, 2016, 00:00

  • Comparative Analysis Of Medication Possession Ratio Measures For Adherence To Single-Medication

    Nov 1, 2016, 00:00

  • Factors Influencing the Pharmacokinetics of Sunitinib and its Active Metabolite in MRCC Patients Receiving an Attenuated Sunitinib Dosing Regimen

    Nov 1, 2016, 00:00

  • The Choice Between HIP Prosthetic Implants in Total HIP Replacement- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Evaluation of Attitude and Perception of Retail Pharmacists Towards Patient Safety

    Nov 1, 2016, 00:00

  • Autoinjector Preference Among Patients with Multiple Sclerosis- Results From A National Survey

    Nov 1, 2016, 00:00

  • Economic Burden of Schizophrenia in Italy- A Probabilistic Cost of Illness Analysis

    Nov 1, 2016, 00:00

  • Concordance of Health Technology Assessment Recommendations of Diabetes, Hepatitis, Oncology and Epilepsy Pharmaceutical Products by Five Agencies within Europe- An Interrater Reliability and Association Analysis

    Nov 1, 2016, 00:00

  • Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rotavirus Vaccination in Hangzhou, China- A Comparison Between two Vaccines

    Nov 1, 2016, 00:00

  • Relapse Rates and Healthcare Resource use of Therapy Persistent And Non-Persistent Multiple Sclerosis Patients In Germany – A Real World Analysis

    Nov 1, 2016, 00:00

  • Implications of Total Budget Impact on Oncology Drug Pricing in The us And EU5

    Nov 1, 2016, 00:00

  • Budget Impact Estimation of Changes In Reimbursement of Basal Insulin Therapies in Hungary

    Nov 1, 2016, 00:00

  • The Importance of Conitec Recommendation about Analogues Insulins of The Treatment of Diabetes Type 1

    Nov 1, 2016, 00:00

  • Development of a Guidance on the Implementation and use of EORTC Instruments in Electronic Applications

    Nov 1, 2016, 00:00

  • Pharmaceutical Reimbursement Of Innovative Medicinal Products In Belgium

    Nov 1, 2016, 00:00

  • Balancing Commercial Confidentiality with Accountability- A Proposal for Enhanced Disclosure of Cost-Effectiveness Decisions

    Nov 1, 2016, 00:00

  • Ofatumumab As A Combination Therapy Versus Other Treatment Regimens in Patients with Untreated, Relapsed or Refractory Chronic Lymphocytic Leukaemia- A Systematic Review of Randomised Controlled Trials

    Nov 1, 2016, 00:00

  • Systematic Review of Cost-Effectiveness Analysis (CEA) of The Cell Free DNA (CFDNA) / Non-Invasive Prenatal Test (NIPT) for Trisomy 21 (T21) Screening

    Nov 1, 2016, 00:00

  • A First Cost-Effectiveness Analysis Based on Real Life Clinical Outcomes of Bevacizumab+ Paclitaxel Compared to Paclitaxel Among French Patients with HER2- Metastatic Breast Cancer in First Line of Treatment

    Nov 1, 2016, 00:00

  • Rates And Predictors Of Short Term Disability Claims Among Migraine Patients In The Us

    Nov 1, 2016, 00:00

  • Diabetic Macular Edema, Budget Impact Analysis from the Perspective of the Algerian Public Health System

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications on Smoking Cessation and Relapses Among Elderly Smokers

    Nov 1, 2016, 00:00

  • Evaluation of The Cost Saving Potential of Introducing Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Three Regions In Italy

    Nov 1, 2016, 00:00

  • Mapping the Prescription Trend for Rheumatoid Arthritis in Mumbai, India

    Nov 1, 2016, 00:00

  • A Health Technology Assessment of Home-Based Haemodialysis in Esrd Patients

    Nov 1, 2016, 00:00

  • CARDIOVASCULAR DISORDERS - Patient-Reported Outcomes Patient Preference StudiesTreatment Patterns and Medication Adherence of Acute Ischemic Stroke Patient in Korea

    Nov 1, 2016, 00:00

  • Results from a Model to Forecast The Current and Future Number of Patients Eligible for Treatment of Refractory Advanced Non-Small Cell Lung Cancer (NSCLC) in France, Germany, Italy and Spain

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Acupuncture Versus Standard Care For Pelvic And Low Back Pain In Pregnancy- An Analysis of The Game Randomized Trial

    Nov 1, 2016, 00:00

  • Global Prevalence Estimates of Transthyretin Familial Amyloid Polyneuropathy (ATTR-FAP)- A Systematic Review and Projections

    Nov 1, 2016, 00:00

  • Patient Reported Health Utility in HR+/HER2- Advanced/Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Inpatient Treatment Cost of Post-Stroke- An Analysis in Hospital of Occupational Diseases and Rehabilitation, Vietnam

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Targeted Treatments for Pulmonary Arterial Hypertension (PAH) In Patients Receiving Active Treatments without Adequate Response

    Nov 1, 2016, 00:00

  • Supply-Side and Demand-Side Policies for Biosimilars- An Overview in 10 European Member States

    Nov 1, 2016, 00:00

  • What Happens To Originator Medicines When (Generic) Followers Enter The Public Market

    Nov 1, 2016, 00:00

  • The Association Between Parenting Stress And The Child’s Quality of Life Among Parents of Asthmatic Children

    Nov 1, 2016, 00:00

  • Economic Assessment of Routine Oncotype DX Testing of Estrogen Receptor Positive (ER+) Early Breast Cancer (EBC) Patients with Grade 2 Tumours in Czech Republic

    Nov 1, 2016, 00:00

  • Factors Associated with 90-Day or 180-Day Long-Term Use of Anxiety-Hypnotic Prescriptions and Economic and Safety Outcomes- A Retrospective Cohort Study

    Nov 1, 2016, 00:00

  • Quality of Life for Patients Using Hemodialysis (HD) vs. Peritoneal Dialysis (PD) Modalities in Taiwan

    Nov 1, 2016, 00:00

  • Medication Reconciliation- A Tool for Better Patient Care

    Nov 1, 2016, 00:00

  • Scientific Epidemiology and Health Economics- A Retrospective Analysis on Pesticide Consumption and Survivors in Telangana State-India

    Nov 1, 2016, 00:00

  • Cone Beam Computed Tomography use in Overdenture Abutments Examination- Risk Benefit Analysis

    Nov 1, 2016, 00:00

  • A Retrospective Observational Cohort Study To Investigate Treatment Outcome of Mrsa Patients Administrated with Anti-Mrsa Drugs using Large Insurance Claims Data in Japan

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment of Certolizumab Pegol In Adults With Axial Spondyloarthritis In Mexico

    Nov 1, 2016, 00:00

  • Short And Long Term Costs Associated With Different Cardiovascular Events In Belgium

    Nov 1, 2016, 00:00

  • The Multidisciplinary Risk Assessment and Management Program – Diabetes Mellitus (Ramp-Dm) was Cost-Effective for Managing Patients with Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Measuring Treatment Satisfaction and Preference in Patients with Asthma and Copd- Results of A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Developing and Testing A Stated-Preference Instrument to Prioritize Treatment Goals Among Patients with Recent Onset Schizophrenia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab in Patients with Advanced or Metastatic Renal Cell Carcinoma in Portugal

    Nov 1, 2016, 00:00

  • Adjusted Comparison of Daratumumab Monotherapy Versus Real-World Historical Control Data From The Czech Republic in Heavily Pre-Treated and Highly Refractory Multiple Myeloma Patients

    Nov 1, 2016, 00:00

  • Investigating the Effects of Testing and Adjusting for Nonlinearity using Categorization in Prediction Models with Costs as Outcome

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Cementless Versus Cemented Prostheses for Total HIP Arthroplasty From A UK Hospital Perspective

    Nov 1, 2016, 00:00

  • Are We Indeed Fast Adopters As We Claim To Be? An Analysis Of The Time Interval From Regulatory Approval To Coverage And Reimbursement In The National List Of Health Services In Israel

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Panitumumab Compared with Cetuximab in the First-Line Treatment of Wild-Type RAS Metastatic Colorectal Cancer Patients in Brazil

    Nov 1, 2016, 00:00

  • Further Validation of the Haemopref in a Real-World Setting

    Nov 1, 2016, 00:00

  • Access to Anti-Cancer Drugs In India- Is There a Need to Revise Reimbursement Policies?

    Nov 1, 2016, 00:00

  • A Systematic Review of Cardiovascular Event Utilities in Asia

    Nov 1, 2016, 00:00

  • Cost Assessment Of Antibiotics Use In A Hospital In The Dominican Republic

    Nov 1, 2016, 00:00

  • Colorectal Cancer Treatment Costs in Estonia

    Nov 1, 2016, 00:00

  • patient Characteristics and Treatment Patterns of Venous Thromboembolism (Vte) Among Hospitalized Patients in China- an Analysis of Electronic Medical Record Data

    Nov 1, 2016, 00:00

  • Current Reimbursement Situation of Advanced Therapy Medicinal Products (ATMP) in Germany- Which Strategy to Secure Adequate Funding?

    Nov 1, 2016, 00:00

  • Assessment Of General Knowledge Concerning Health-Related Topics

    Nov 1, 2016, 00:00

  • Clinical and Economic Outcomes of Venous Thromboembolism (VTE) Among Hospitalized Patients in China- An Analysis of Electronic Medical Record Data

    Nov 1, 2016, 00:00

  • Anticipated Impact of EU5 Payer Policy on Prescribing of Novel Biologic Therapies In Asthma

    Nov 1, 2016, 00:00

  • Incremental Direct And Indirect Costs Associated With Migraine In The Us

    Nov 1, 2016, 00:00

  • Private and Catastrophic Health Expenditure of Patients with Early and Locally Advanced Breast Cancer in Greece

    Nov 1, 2016, 00:00

  • Policy Objective of Generic Medicines from the Investment Perspective- The Case of Clopidogrel

    Nov 1, 2016, 00:00

  • Trading-Off Quality of Life and Survival Time – Feasibility of Web-Based Discrete Choice Experiments For QLU-C10D Utility Elicitation in Cancer Patients

    Nov 1, 2016, 00:00

  • Utilisation and Expenditure Beyond HTA- A Case Study of Lidocaine 5% Medicated Plaster

    Nov 1, 2016, 00:00

  • Understanding the Utility Value of Patients with Heavily Pre-Treated Multiple Myeloma

    Nov 1, 2016, 00:00

  • Impact of Dosing Schedule on the Success of A Vaccination Programme in an Elderly Population

    Nov 1, 2016, 00:00

  • The Probabilistic Efficiency Frontier- A Value Assessment Of Treatment Options In Hepatitis C

    Nov 1, 2016, 00:00

  • Prevalence, Perception And Reasons For Self Medication

    Nov 1, 2016, 00:00

  • prevalence of Anticholinergic Drug Use in Older Adults With Dementia

    Nov 1, 2016, 00:00

  • Direct Medical Costs of Hcv Patients Using National Health Insurance Claims Data in South Korea

    Nov 1, 2016, 00:00

  • European Regulators and Payers Initiatives for Drug Access- Collaborations or Divergences?

    Nov 1, 2016, 00:00

  • Evaluation of The Comparability of Scores From Cat and Short-Form

    Nov 1, 2016, 00:00

  • Assessment Of Price Of Essential Medicines In India

    Nov 1, 2016, 00:00

  • Patient Characteristics And Health Outcomes In Adults Diagnosed With Marfan Syndrome In The United States

    Nov 1, 2016, 00:00

  • Evaluation of Antibacterial and Cytotoxic Effects of Gymnema Sylvestre R.BR. Species Cultivated in Pakistan Against Common Resistant Pathogens

    Nov 1, 2016, 00:00

  • Three Methods for Measuring Productivity Losses Due to Health Related Presenteeism in Economic Evaluations

    Nov 1, 2016, 00:00

  • Effectiveness of Photodynamic Therapy in Patients with Localized Esophageal Cancer

    Nov 1, 2016, 00:00

  • When Is The Use Of A Systematic Literature Review Appropriate? A Comparison Of Systematic, Rapid, And Scoping Reviews And Their Application To The Hta Process

    Nov 1, 2016, 00:00

  • Insights for Care- Comparison of Healthcare Utilisation and Cost Impact of Managing Diabetes Patients with Hypoglycaemia to Patients with Heart Failure or Stroke Using Real-World Evidence Data from an Urban Healthcare System in Birmingham, ...

    Nov 1, 2016, 00:00

  • The Cost of Glycaemic Target Achievement with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (MET+SU) in the UK

    Nov 1, 2016, 00:00

  • Predicting Response To Anti-Vascular Endothelial Growth Factor Treatment Using Electronic Medical Record Data In Eyes With Neovascular Age-Related Macular Degeneration

    Nov 1, 2016, 00:00

  • 5-Year Overall Survival and Progression-Free Survival in Multiple Myeloma by Line of Treatment from the French Hematologic Malignancy Registry

    Nov 1, 2016, 00:00

  • Application of Healthcare Failure Mode Effect Analysis in Improving Patient Education at an Outpatient Department af a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Is There an Association Between Diabetic Microvascular Complications and Serum Cholesterol? a Retrospective Analysis among Malaysian Patients with T2DM

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results From a Survey of Clinicians in Japan

    Nov 1, 2016, 00:00

  • Regional Time To Market Of Innovative Drugs In Italy

    Nov 1, 2016, 00:00

  • Pegaspargase Versus Asparaginase In Childhood Acute Lymphoblastic Leukemia- A Cost-Minimization Analysis In France

    Nov 1, 2016, 00:00

  • Breast Cancer In Japan- Room For Improved Screening

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Ranibizumab Compared to Dexamethasone in Patients with Retinal Vein Occlusion (RVO) from A Portuguese Health Care Perspective

    Nov 1, 2016, 00:00

  • Validation of Model-Simulated Clinical Outcomes of Antiplatelet Therapies in Patients with Acute Coronary Syndrome

    Nov 1, 2016, 00:00

  • Linguistic Validation Of The Finnish Version Of The Modified Mobility Section Of The Prosthesis Evaluation Questionnaire

    Nov 1, 2016, 00:00

  • The Therapeutic Indication of Injectable Bevacizumab to The Treatment of Age-Related Muscular Degeneration

    Nov 1, 2016, 00:00

  • Development of a Global Model for the Economic Evaluation of Pharmacogenomics Tests for Early-Stage Breast Cancer Treatment

    Nov 1, 2016, 00:00

  • Market Exclusivity Periods And Patent Challenges In Pharmaceuticals In South Korea

    Nov 1, 2016, 00:00

  • An Economic Model of Advance Care Planning- A Cost Effective Intervention for People with Dementia

    Nov 1, 2016, 00:00

  • Hospitalization Costs Associated with Crohn's Disease and Ulcerative Colitis in Belgium

    Nov 1, 2016, 00:00

  • The Impact Of Regional Legislative Measures On The Prescription Of Off-Patent Medicines

    Nov 1, 2016, 00:00

  • Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for the Treatment of Type 2 Diabetes Mellitus in the Spanish Setting

    Nov 1, 2016, 00:00

  • Generic drugs- do they offer the same safety and efficacy as originator medicines? -perceptions and attitudes of final year pharmacy students in greece

    Nov 1, 2016, 00:00

  • Analysis of Rational Medication for Cardiovascular Diseases in Fujian, China

    Nov 1, 2016, 00:00

  • Estimating the Impact of Direct-to-Consumer Advertising of Pharmacy Only Medicine Using Discrete Choice Experiments

    Nov 1, 2016, 00:00

  • Health State Utilities in Chronic Heart Failure in The UK- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Injecting A "Dexamethasone Ropivacaine" Mixture Subcutaneously In The Management of Traumatic Bone Surgeries of The Forefoot

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Using Factor VII + Von Willebrand Factor In Treatment of Patients with Von Willebrand Disease

    Nov 1, 2016, 00:00

  • A Dynamic Simulation to Investigate Health Economic Impact of a Pulmonary Artery Pressure Sensor for Heart Failure Telemonitoring

    Nov 1, 2016, 00:00

  • Prevalence, Pharmaceutical Expenditures and Patient's Factors of High-Risk Medication used among Elderly Inpatients at a District Hospital in the South of Thailand

    Nov 1, 2016, 00:00

  • Review of Health Technology Assessment (HTA) Requirements for Rare Diseases Across European Countries

    Nov 1, 2016, 00:00

  • Cross-Cultural Adaptation of the Zarit Caregiver Interview for Alzheimer's Disease (ZCI-AD) and the Caregiver Global Impression Scales in 13 Languages

    Nov 1, 2016, 00:00

  • • Analysis of The Factors Affecting Parents’ Medication Adherence In Asthmatic Children Using Expectation Confirmation Theory

    Nov 1, 2016, 00:00

  • Cancer Drugs in Europe- A Comparison of HTA Processes and Decisions for New and Innovative Oncology Therapies in France, Germany and The UK – An Analysis Using The Prismaccess Database

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Ruxolitinib Versus Best Available Therapy For The Treatment of Myelofibrosis From Public Health Perspective In Chile

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72 (current)
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »